7. “Study of Lenalidomide to Evaluate Safety and Effectiveness in Patients With Diffuse Large B-Cell Lymphoma (DLBCL)” has already finished recruitment and is ongoing at the Celgene Corporation.
We are sorry that this post was not useful for you!
Let us improve this post!
Tell us how we can improve this post?